Open AccessPostcovid pulmonary complication
Author(s) -
Tomasz Korzec,
Przemysław Raczkiewicz,
Maria Kalicka,
Konrad Kania,
Katarzyna Cyboran
Publication year - 2021
Publication title -
journal of education, health and sport
Language(s) - English
Resource type - Journals
ISSN - 2391-8306
DOI - 10.12775/jehs.2021.11.09.010
Subject(s) - covid-19 , medicine , pulmonary fibrosis , lung , complication , pandemic , virus , incubation period , pulmonary embolism , disease , fibrosis , lung disease , virology , intensive care medicine , pathology , incubation , infectious disease (medical specialty) , biology , biochemistry
The World Health Organization in March 2020 announced a pandemic of COVID-19 disease caused by the SARS-CoV-2 virus. It is one of the seven species known to be pathogenic to humans in this group of viruses. The incubation period of the virus is 2-14 days, usually about 5 days. SARS-CoV-2 uses the ACE2 receptor to enter the host's mucosa and cause an active infection. Symptomatic infection may be complicated by reversible or irreversible changes in the lungs and pulmonary embolism. Method: Recent literature was reviewed based on PubMEd, Google scholar, using words: covid lung, post covid lung, post covid, covid lung fibrosis, Objective: Systematisation of information on pulmonary postovid complications